Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
de Barros HA, Remmers S, Luiting HB, van Leenders GJLH, Roobol MJ, Bekers EM, Amin A, Haynes AM, Delprado W, Stricker PD, van der Poel HG, van der Kwast TH, van Leeuwen PJ. de Barros HA, et al. Among authors: van leeuwen pj, van der kwast th, van der poel hg, van leenders gjlh. Urology. 2022 Oct;168:156-164. doi: 10.1016/j.urology.2022.04.043. Epub 2022 Jul 5. Urology. 2022. PMID: 35803346
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.
van der Aa MN, van Leenders GJ, Steyerberg EW, van Rhijn BW, Jöbsis AC, Zwarthoff EC, van der Kwast TH. van der Aa MN, et al. Among authors: van rhijn bw, van leenders gj, van der kwast th. Hum Pathol. 2005 Sep;36(9):981-6. doi: 10.1016/j.humpath.2005.06.017. Hum Pathol. 2005. PMID: 16153461
Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer.
van der Kwast TH, Ciatto S, Martikainen PM, Hoedemaeker R, Laurila M, Pihl CG, Hugosson J, Neetens I, Nelen V, Di Lollo S, Roobol MJ, Määtänen L, Santonja C, Moss S, Schröder FH. van der Kwast TH, et al. Int J Cancer. 2006 May 15;118(10):2538-42. doi: 10.1002/ijc.21667. Int J Cancer. 2006. PMID: 16353141 Clinical Trial.
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
Postma R, Schröder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH. Postma R, et al. Among authors: van leenders gj, van der kwast th. Eur Urol. 2007 Jul;52(1):89-97. doi: 10.1016/j.eururo.2007.01.030. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17257742 Clinical Trial.
Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?
Wolters T, Roobol MJ, Schröder FH, van der Kwast TH, Roemeling S, van der Cruijsen-Koeter IW, Bangma CH, van Leenders GJ; ERSPC Rotterdam section. Wolters T, et al. Among authors: van leenders gj, van der cruijsen koeter iw, van der kwast th. BJU Int. 2008 Feb;101(3):283-8. doi: 10.1111/j.1464-410X.2007.07267.x. Epub 2007 Oct 8. BJU Int. 2008. PMID: 17922858 Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
482 results